Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SO vs MRNA✓SelectedUSD · MRNASO vs MRNA performance historyLatest closeAs of+1.95%11/16
Stock and ETF performance explorer

SO vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+174.3%
MRNA return
+878.5%
Excess return
-704.2%
Maximum drawdown
-38.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.9%-3.6%+5.6%+2.0%
7D+2.0%-20.0%+21.9%+2.1%
30D+4.6%-1.3%+5.9%+4.6%
3M+3.7%+240.0%-236.3%+1.5%
6M+4.8%+339.0%-334.2%+2.1%
YTD+12.1%+630.0%-617.9%+7.9%
1Y+8.7%+769.1%-760.4%+4.2%
3Y+50.6%+181.2%-130.6%+46.1%
5Y+82.8%-8.1%+90.9%+80.4%
All+174.3%+878.5%-704.2%+145.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling